|
|
transmembrane transport
|
GO:0055085 |
412 |
0.084
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.074
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.063
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.062
|
Mouse |
|
|
male gamete generation
|
GO:0048232 |
285 |
0.060
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.059
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.058
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.055
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.054
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.050
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.048
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.044
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.044
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.042
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.041
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.040
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.040
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.040
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.040
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.039
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.039
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.038
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.038
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.038
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.037
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.037
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.036
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.036
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.036
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.036
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.036
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.036
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.035
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.035
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.034
|
|
|
|
negative regulation of apoptotic process involved in outflow tract morphogenesis
|
GO:1902257 |
2 |
0.034
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.033
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.033
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.033
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.033
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.033
|
|
|
|
regulation of transcription from rna polymerase iii promoter
|
GO:0006359 |
2 |
0.033
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.033
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.033
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.032
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.032
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.032
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.031
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.031
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.031
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.031
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.031
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.030
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.030
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.029
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.029
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.029
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.029
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.029
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.029
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.028
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.028
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.028
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.028
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.028
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.028
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.027
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.027
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.027
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.027
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.027
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.027
|
|
|
|
hormone metabolic process
|
GO:0042445 |
86 |
0.026
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.026
|
|
|
|
pattern specification involved in metanephros development
|
GO:0072268 |
4 |
0.026
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.026
|
|
|
|
tube formation
|
GO:0035148 |
140 |
0.026
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.026
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.026
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.026
|
|
|
|
stem cell proliferation
|
GO:0072089 |
117 |
0.026
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.025
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.025
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.025
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.025
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.025
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.024
|
|
|
|
cell division
|
GO:0051301 |
120 |
0.024
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.024
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.024
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.024
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.024
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.024
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.024
|
|
|
|
spermatid differentiation
|
GO:0048515 |
115 |
0.024
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.024
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.024
|
|
|
|
regulation of embryonic development
|
GO:0045995 |
71 |
0.023
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.023
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.023
|
|
|
|
positive regulation of cell cycle
|
GO:0045787 |
92 |
0.023
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.023
|
|
|
|
columnar cuboidal epithelial cell differentiation
|
GO:0002065 |
82 |
0.023
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.023
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.023
|
|
|
|
nephron development
|
GO:0072006 |
109 |
0.022
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.022
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.022
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.022
|
|
|
|
synapse organization
|
GO:0050808 |
125 |
0.022
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.022
|
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.022
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.022
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.022
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.022
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.021
|
|
|
|
blastocyst development
|
GO:0001824 |
80 |
0.021
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.021
|
|
|
|
action potential
|
GO:0001508 |
78 |
0.021
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.021
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.021
|
|
|
|
segmentation
|
GO:0035282 |
93 |
0.021
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.021
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.021
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.021
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.021
|
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.020
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.020
|
|
|
|
steroid metabolic process
|
GO:0008202 |
119 |
0.020
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.020
|
|
|
|
neural precursor cell proliferation
|
GO:0061351 |
121 |
0.020
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.020
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.020
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.020
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.020
|
|
|
|
neural tube formation
|
GO:0001841 |
108 |
0.020
|
|
|
|
activation of immune response
|
GO:0002253 |
138 |
0.019
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.019
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.019
|
|
|
|
glomerular mesangial cell differentiation
|
GO:0072008 |
3 |
0.019
|
|
|
|
exocytosis
|
GO:0006887 |
121 |
0.019
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.019
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.019
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.019
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.019
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.019
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.019
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.019
|
|
|
|
paraxial mesodermal cell differentiation
|
GO:0048342 |
2 |
0.019
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.019
|
|
|
|
neuron neuron synaptic transmission
|
GO:0007270 |
69 |
0.019
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.019
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.019
|
|
|
|
cardiac chamber development
|
GO:0003205 |
108 |
0.019
|
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.019
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
123 |
0.019
|
|
|
|
lymphocyte mediated immunity
|
GO:0002449 |
139 |
0.019
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.019
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.019
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.019
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.019
|
|
|
|
kidney epithelium development
|
GO:0072073 |
121 |
0.019
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.018
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.018
|
|
|
|
oocyte axis specification
|
GO:0007309 |
2 |
0.018
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.018
|
|
|
|
primary neural tube formation
|
GO:0014020 |
95 |
0.018
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.018
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.018
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.018
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.018
|
|
|
|
t cell proliferation
|
GO:0042098 |
120 |
0.018
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.018
|
|
|
|
carbon catabolite activation of transcription
|
GO:0045991 |
4 |
0.018
|
|
|
|
stem cell maintenance
|
GO:0019827 |
130 |
0.018
|
|
|
|
regulation of feeding behavior
|
GO:0060259 |
3 |
0.018
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.017
|
|
|
|
anion transport
|
GO:0006820 |
177 |
0.017
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.017
|
|
|
|
alcohol metabolic process
|
GO:0006066 |
116 |
0.017
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.017
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.017
|
|
|
|
fatty acid metabolic process
|
GO:0006631 |
121 |
0.017
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.017
|
|
|
|
response to light stimulus
|
GO:0009416 |
135 |
0.017
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.017
|
|
|
|
detection of stimulus
|
GO:0051606 |
84 |
0.017
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.017
|
|
|
|
intracellular mrna localization
|
GO:0008298 |
4 |
0.017
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.017
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.017
|
|
|
|
cell junction maintenance
|
GO:0034331 |
4 |
0.017
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.017
|
|
|
|
metanephric loop of henle development
|
GO:0072236 |
4 |
0.017
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.017
|
|
|
|
retina development in camera type eye
|
GO:0060041 |
119 |
0.017
|
|
|
|
calcium ion dependent exocytosis
|
GO:0017156 |
35 |
0.017
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.017
|
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.017
|
|
|
|
cell cell junction organization
|
GO:0045216 |
72 |
0.017
|
|
|
|
oviduct development
|
GO:0060066 |
3 |
0.017
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.017
|
|
|
|
monosaccharide metabolic process
|
GO:0005996 |
106 |
0.016
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.016
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.016
|
|
|
|
mesangial cell differentiation
|
GO:0072007 |
4 |
0.016
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.016
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.016
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.016
|
|
|
|
neural tube closure
|
GO:0001843 |
90 |
0.016
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.016
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.016
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.016
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.016
|
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.016
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.016
|
|
|
|
regulation of binding
|
GO:0051098 |
111 |
0.016
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.016
|
|
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.016
|
|
|
|
regulation of actin filament based process
|
GO:0032970 |
99 |
0.016
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.016
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.016
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.016
|
|
|
|
regulation of bmp signaling pathway
|
GO:0030510 |
60 |
0.016
|
|
|
|
carbon catabolite repression of transcription from rna polymerase ii promoter
|
GO:0000437 |
1 |
0.016
|
|
|
|
transcription from rna polymerase iii promoter
|
GO:0006383 |
3 |
0.016
|
|
|
|
positive regulation of cell projection organization
|
GO:0031346 |
95 |
0.016
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.016
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.015
|
|
|
|
paraxial mesodermal cell fate commitment
|
GO:0048343 |
2 |
0.015
|
|
|
|
prostate gland stromal morphogenesis
|
GO:0060741 |
2 |
0.015
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.015
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.015
|
|
|
|
cell junction organization
|
GO:0034330 |
77 |
0.015
|
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.015
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.015
|
|
|
|
single fertilization
|
GO:0007338 |
82 |
0.015
|
|
|
|
glucose metabolic process
|
GO:0006006 |
92 |
0.015
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
122 |
0.015
|
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.015
|
|
|
|
neuromuscular process
|
GO:0050905 |
99 |
0.015
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.015
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.015
|
|
|
|
hexose metabolic process
|
GO:0019318 |
98 |
0.015
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.015
|
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.015
|
|
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.015
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.015
|
|
|
|
regulation of cell substrate adhesion
|
GO:0010810 |
73 |
0.015
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.015
|
|
|
|
rhodopsin mediated signaling pathway
|
GO:0016056 |
4 |
0.015
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.015
|
|
|
|
negative regulation of hormone biosynthetic process
|
GO:0032353 |
4 |
0.015
|
|
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
139 |
0.015
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.015
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.015
|
|
|
|
detection of abiotic stimulus
|
GO:0009582 |
60 |
0.015
|
|
|
|
hindbrain development
|
GO:0030902 |
128 |
0.015
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.015
|
|
|
|
organic anion transport
|
GO:0015711 |
137 |
0.014
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.014
|
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.014
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.014
|
|
|
|
somitogenesis
|
GO:0001756 |
69 |
0.014
|
|
|
|
immune response regulating signaling pathway
|
GO:0002764 |
125 |
0.014
|
|
|
|
secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development
|
GO:0060528 |
4 |
0.014
|
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.014
|
|
|
|
lipid modification
|
GO:0030258 |
65 |
0.014
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.014
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.014
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.014
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.014
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.014
|
|
|
|
tube closure
|
GO:0060606 |
91 |
0.014
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.014
|
|
|
|
positive regulation of cell adhesion
|
GO:0045785 |
80 |
0.014
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.014
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.014
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.014
|
|
|
|
calcium independent cell cell adhesion via plasma membrane cell adhesion molecules
|
GO:0016338 |
4 |
0.014
|
Mouse |
|
|
inner ear morphogenesis
|
GO:0042472 |
101 |
0.014
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.014
|
|
|
|
positive regulation of cell cycle process
|
GO:0090068 |
61 |
0.014
|
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.014
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.014
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.014
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.014
|
|
|
|
epithelial mesenchymal signaling involved in prostate gland development
|
GO:0060738 |
2 |
0.014
|
|
|
|
pole plasm assembly
|
GO:0007315 |
2 |
0.014
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.014
|
|
|
|
regulation of vascular wound healing
|
GO:0061043 |
2 |
0.014
|
|
|
|
myotube cell development
|
GO:0014904 |
60 |
0.014
|
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
93 |
0.014
|
|
|
|
positive regulation of nucleotide catabolic process
|
GO:0030813 |
88 |
0.014
|
|
|
|
neural crest cell development
|
GO:0014032 |
48 |
0.014
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.014
|
|
|
|
myotube differentiation
|
GO:0014902 |
105 |
0.014
|
|
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
145 |
0.014
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.014
|
|
|
|
regulation of circadian sleep wake cycle
|
GO:0042749 |
3 |
0.014
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.014
|
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
118 |
0.013
|
|
|
|
adult locomotory behavior
|
GO:0008344 |
91 |
0.013
|
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
94 |
0.013
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
114 |
0.013
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.013
|
|
|
|
positive regulation of transcription from rna polymerase ii promoter by glucose
|
GO:0000432 |
3 |
0.013
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.013
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.013
|
|
|
|
positive regulation of transcription from rna polymerase iii promoter
|
GO:0045945 |
1 |
0.013
|
|
|
|
chromatin modification
|
GO:0016568 |
187 |
0.013
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.013
|
|
|
|
adaptive immune response
|
GO:0002250 |
155 |
0.013
|
|
|
|
negative regulation of organelle organization
|
GO:0010639 |
90 |
0.013
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.013
|
|
|
|
male sex differentiation
|
GO:0046661 |
109 |
0.013
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.013
|
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
114 |
0.013
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.013
|
|
|
|
sensory perception of light stimulus
|
GO:0050953 |
54 |
0.013
|
|
|
|
regulation of renal sodium excretion
|
GO:0035813 |
3 |
0.013
|
|
|
|
cardiocyte differentiation
|
GO:0035051 |
87 |
0.013
|
|
|
|
rna processing
|
GO:0006396 |
105 |
0.013
|
|
|
|
metanephric nephron development
|
GO:0072210 |
34 |
0.013
|
|
|
|
cellular carbohydrate metabolic process
|
GO:0044262 |
119 |
0.013
|
|
|
|
midgut development
|
GO:0007494 |
4 |
0.013
|
|
|
|
skeletal muscle cell differentiation
|
GO:0035914 |
66 |
0.013
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
155 |
0.013
|
|
|
|
cell fate specification
|
GO:0001708 |
72 |
0.013
|
|
|
|
positive regulation of necrotic cell death
|
GO:0010940 |
1 |
0.013
|
|
|
|
oligopeptide transmembrane transport
|
GO:0035672 |
4 |
0.013
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.013
|
|
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
129 |
0.013
|
|
|
|
maternal determination of anterior posterior axis embryo
|
GO:0008358 |
2 |
0.013
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.013
|
|
|
|
carbon catabolite activation of transcription from rna polymerase ii promoter
|
GO:0000436 |
4 |
0.013
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.013
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.013
|
|
|
|
asymmetric stem cell division
|
GO:0098722 |
3 |
0.013
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.013
|
|
|
|
negative regulation of neuron death
|
GO:1901215 |
98 |
0.013
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.013
|
|
|
|
positive regulation of nucleoside metabolic process
|
GO:0045979 |
91 |
0.013
|
|
|
|
cell differentiation involved in kidney development
|
GO:0061005 |
33 |
0.013
|
|
|
|
nephron tubule development
|
GO:0072080 |
84 |
0.013
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.013
|
|
|
|
female somatic sex determination
|
GO:0019101 |
1 |
0.013
|
|
|
|
carbon catabolite regulation of transcription from rna polymerase ii promoter
|
GO:0000429 |
4 |
0.013
|
|
|
|
mesenchymal cell development
|
GO:0014031 |
93 |
0.013
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.013
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.013
|
|
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.012
|
|
|
|
regulation of protein catabolic process
|
GO:0042176 |
108 |
0.012
|
|
|
|
regulation of synaptic growth at neuromuscular junction
|
GO:0008582 |
4 |
0.012
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.012
|
|
|
|
sodium ion transmembrane transport
|
GO:0035725 |
49 |
0.012
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.012
|
|
|
|
somite development
|
GO:0061053 |
81 |
0.012
|
|
|
|
negative regulation of hydrolase activity
|
GO:0051346 |
71 |
0.012
|
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
144 |
0.012
|
|
|
|
spermatid development
|
GO:0007286 |
108 |
0.012
|
|
|
|
metanephric capsule specification
|
GO:0072267 |
1 |
0.012
|
|
|
|
regulation of map kinase activity
|
GO:0043405 |
120 |
0.012
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.012
|
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
133 |
0.012
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.012
|
|
|
|
ectoderm formation
|
GO:0001705 |
3 |
0.012
|
|
|
|
meiotic cell cycle
|
GO:0051321 |
122 |
0.012
|
|
|
|
actin filament organization
|
GO:0007015 |
113 |
0.012
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.012
|
|
|
|
mesenchymal cell differentiation
|
GO:0048762 |
107 |
0.012
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.012
|
|
|
|
mitochondrion distribution
|
GO:0048311 |
4 |
0.012
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.012
|
|
|
|
vascular wound healing
|
GO:0061042 |
3 |
0.012
|
|
|
|
oocyte construction
|
GO:0007308 |
2 |
0.012
|
|
|
|
mrna metabolic process
|
GO:0016071 |
84 |
0.012
|
|
|
|
cardiac muscle cell differentiation
|
GO:0055007 |
69 |
0.012
|
|
|
|
regulation of cell migration involved in sprouting angiogenesis
|
GO:0090049 |
4 |
0.012
|
|
|
|
antigen receptor mediated signaling pathway
|
GO:0050851 |
64 |
0.012
|
|
|
|
granulosa cell differentiation
|
GO:0060014 |
1 |
0.012
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.012
|
|
|
|
renal sodium excretion
|
GO:0035812 |
3 |
0.012
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.012
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.012
|
|
|
|
renal tubule development
|
GO:0061326 |
87 |
0.012
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.012
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.012
|
|
|
|
epithelium migration
|
GO:0090132 |
63 |
0.012
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.012
|
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
79 |
0.012
|
|
|
|
glomerular mesangial cell development
|
GO:0072144 |
3 |
0.012
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.012
|
|
|
|
muscle fiber development
|
GO:0048747 |
76 |
0.012
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.012
|
|
|
|
mesangial cell development
|
GO:0072143 |
4 |
0.012
|
|
|
|
hormone secretion
|
GO:0046879 |
128 |
0.012
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.012
|
|
|
|
regulation of cell projection assembly
|
GO:0060491 |
38 |
0.012
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.012
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.012
|
|
|
|
negative regulation of epithelial cell proliferation
|
GO:0050680 |
64 |
0.012
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.011
|
|
|
|
sensory system development
|
GO:0048880 |
3 |
0.011
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.011
|
|
|
|
regulation of postsynaptic membrane potential
|
GO:0060078 |
48 |
0.011
|
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.011
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.011
|
|
|
|
skeletal muscle fiber development
|
GO:0048741 |
58 |
0.011
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.011
|
|
|
|
cell activation involved in immune response
|
GO:0002263 |
126 |
0.011
|
|
|
|
regulation of apoptotic process involved in outflow tract morphogenesis
|
GO:1902256 |
2 |
0.011
|
|
|
|
nephron epithelium development
|
GO:0072009 |
92 |
0.011
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.011
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.011
|
|
|
|
regulation of carbohydrate metabolic process
|
GO:0006109 |
75 |
0.011
|
|
|
|
positive regulation of cell motility
|
GO:2000147 |
116 |
0.011
|
|
|
|
female sex determination
|
GO:0030237 |
1 |
0.011
|
|
|
|
cellular response to extracellular stimulus
|
GO:0031668 |
81 |
0.011
|
|
|
|
ear morphogenesis
|
GO:0042471 |
118 |
0.011
|
|
|
|
glomerulus development
|
GO:0032835 |
40 |
0.011
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.011
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.011
|
|
|
|
metanephros development
|
GO:0001656 |
79 |
0.011
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.011
|
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.011
|
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
140 |
0.011
|
|
|
|
smoothened signaling pathway
|
GO:0007224 |
105 |
0.011
|
|
|
|
response to amino acid
|
GO:0043200 |
37 |
0.011
|
|
|
|
regulation of tongue muscle cell differentiation
|
GO:2001035 |
2 |
0.011
|
|
|
|
cerebellum development
|
GO:0021549 |
77 |
0.011
|
|
|
|
cellular response to biotic stimulus
|
GO:0071216 |
92 |
0.011
|
|
|
|
positive regulation of immature t cell proliferation
|
GO:0033091 |
4 |
0.011
|
|
|
|
negative regulation of transcription from rna polymerase ii promoter by glucose
|
GO:0000433 |
1 |
0.011
|
|
|
|
nerve development
|
GO:0021675 |
67 |
0.011
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.011
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.011
|
|
|
|
positive regulation of canonical wnt signaling pathway involved in controlling type b pancreatic cell proliferation
|
GO:2000081 |
1 |
0.011
|
|
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
133 |
0.011
|
|
|
|
regulation of cellular carbohydrate metabolic process
|
GO:0010675 |
75 |
0.011
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
114 |
0.011
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.011
|
|
|
|
interleukin 6 production
|
GO:0032635 |
58 |
0.011
|
|
|
|
regulation of cellular component size
|
GO:0032535 |
121 |
0.011
|
|
|
|
heart contraction
|
GO:0060047 |
93 |
0.011
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.011
|
|
|
|
positive regulation of sequence specific dna binding transcription factor activity
|
GO:0051091 |
68 |
0.011
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.010
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.010
|
|
|
|
cardiac ventricle development
|
GO:0003231 |
83 |
0.010
|
|
|
|
regulation of ph
|
GO:0006885 |
26 |
0.010
|
|
|
|
leukocyte apoptotic process
|
GO:0071887 |
71 |
0.010
|
|
|
|
negative regulation of protein processing
|
GO:0010955 |
79 |
0.010
|
|
|
|
planar cell polarity pathway involved in outflow tract morphogenesis
|
GO:0061347 |
2 |
0.010
|
|
|
|
detection of external stimulus
|
GO:0009581 |
61 |
0.010
|
|
|
|
reflex
|
GO:0060004 |
22 |
0.010
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.010
|
|
|
|
regulation of mesenchymal cell proliferation involved in ureter development
|
GO:0072199 |
3 |
0.010
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.010
|
|
|
|
t cell receptor signaling pathway
|
GO:0050852 |
46 |
0.010
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.010
|
|
|
|
regulation of reproductive process
|
GO:2000241 |
66 |
0.010
|
|
|
|
organelle localization
|
GO:0051640 |
179 |
0.010
|
|
|
|
dendrite development
|
GO:0016358 |
115 |
0.010
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.010
|
|
|
|
regulation of neural precursor cell proliferation
|
GO:2000177 |
70 |
0.010
|
|
|
|
regulation of b cell activation
|
GO:0050864 |
81 |
0.010
|
|
|
|
cellularization
|
GO:0007349 |
1 |
0.010
|
|
|
|
embryonic skeletal system development
|
GO:0048706 |
120 |
0.010
|
|
|
|
negative regulation of kinase activity
|
GO:0033673 |
81 |
0.010
|
|
|
|
detection of glucose
|
GO:0051594 |
1 |
0.010
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.010
|
|
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
88 |
0.010
|
|
|
|
renal capsule development
|
GO:0072127 |
1 |
0.010
|
|
|
|
immune response activating signal transduction
|
GO:0002757 |
116 |
0.010
|
|
|
|
regulation of multi organism process
|
GO:0043900 |
111 |
0.010
|
|
|
|
nephron epithelium morphogenesis
|
GO:0072088 |
68 |
0.010
|
|
|
|
positive regulation of gtp catabolic process
|
GO:0033126 |
85 |
0.010
|
|
